Bhubaneswar-based telehealth platform MedTel has raised an undisclosed amount in pre-Series A funding in a round led by a programme jointly run by the British and Indian governments.

The funding was led by Innovative Ventures and Technologies for Development (INVENT), a programme launched by the central government’s Technology Development Board (TDB) in partnership with Department for International Development (DFID), United Kingdom.

The startup will use the fresh infusion to improve its technology and product offerings in addition to expanding to other states.

MedTel runs an artificial intelligence and cloud-based web and mobile platform which brings together pharmacies, pathology labs, doctors and patients.

The startup provides healthcare services for Tier 3-Tier 6 centres through a business-to-business-to-consumer model (B2B2C) model.

MedTel claims to have aggregrated 850 pharmacies and diagnostic centres as digtial health clinics. It offers more than 400 registered specialist doctors with expertise in areas including paediatrics, psychology, caridiology, neurology, oncology and diabetology.